Company Filing History:
Years Active: 2006
Title: Rolf Peter Ryseck: Innovator in the p53 Pathway Modulation
Introduction
Rolf Peter Ryseck is a notable inventor based in Ewing, NJ (US). He has made significant contributions to the field of biotechnology, particularly in understanding the p53 pathway, which is crucial for regulating cell growth and preventing cancer.
Latest Patents
Rolf Peter Ryseck holds a patent titled "PRMTs as modifiers of the p53 pathway and methods of use." This patent identifies human PRMT genes as modulators of the p53 pathway, highlighting their potential as therapeutic targets for disorders associated with defective p53 function. The patent also provides methods for identifying modulators of p53 by screening for agents that can modulate the activity of PRMT.
Career Highlights
Rolf Peter Ryseck is currently associated with Exelixis, Inc., a company known for its focus on developing innovative cancer therapies. His work has contributed to advancing the understanding of cancer biology and potential treatment options.
Collaborations
Throughout his career, Rolf has collaborated with esteemed colleagues, including Lori Friedman and Gregory D Plowman. These collaborations have further enriched his research and development efforts in the field.
Conclusion
Rolf Peter Ryseck's innovative work in the modulation of the p53 pathway exemplifies the critical role of inventors in advancing medical science. His contributions continue to pave the way for new therapeutic strategies in cancer treatment.